Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
clarithromycin (biaxin) (1 trial)
darunavir (prezista) (1 trial)
emtricitabine (emtriva) (2 trials)
esomeprazole (nexium) (1 trial)
levofloxacin (levaquin) (1 trial)
maraviroc (selzentry) (1 trial)
metronidazole (flagyl) (1 trial)
nicotinamide (1 trial)
ofloxacin (floxin) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
raltegravir (isentress) (1 trial)
rifabutin (mycobutin) (1 trial)
rifampin (2 trials)
ritonavir (Norvir) (1 trial)
tenofovir (viread) (2 trials)
tetracycline (tetrex) (1 trial)
ceftriaxone (rocephin) (1 trial)
ciprofloxacin (cipro) (1 trial)
clindamycin (cleocin) (1 trial)
linezolid (zyvox) (1 trial)
sulfamethoxazole (gantanol) (1 trial)
trimethoprim (1 trial)
vancomycin (Vancocin) (1 trial)
dalbavancin (dalvance) (1 trial)
landiolol (1 trial)
tedizolid phosphate (sivextro) (1 trial)
Acute Kidney Injury (Phase 3)
Communicable Diseases (Phase 3)
HIV Infections (Phase 3)
Infections (Phase 3)
Shock (Phase 3)
Shock, Septic (Phase 3)
Trials (9 total)
Trial APIs (26 total)